Do inhaled corticosteroids stunt the growth of children?

Drugs and Therapy Perspectives

Volumn 14, Issue 3, 1999, Pages 12-14

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; TRIAMCINOLONE ACETONIDE;

ASTHMA; CHILD GROWTH; CORTICOSTEROID THERAPY; DRUG SAFETY; GROWTH INHIBITION; GROWTH RETARDATION; HUMAN; PRACTICE GUIDELINE; REVIEW;

EID: 0033516967     PISSN: 11720360     EISSN: None     Source Type: Journal    
DOI: 10.2165/00042310-199914030-00004     Document Type: Review

References (19)

1. 1. T Earl 1999 The growing debate over corticosteroids in paediatric patients Reactions 749 3 4 10.2165/00128415-199907490-00003 Earl T. The growing debate over corticosteroids in paediatric patients. Reactions 1999 May 1; 749: 3–4
2. 2. Curr Probl Pharmacovigilance 1998 24 5 The safety of inhaled and nasal corticosteroids. Curr Probl Pharmacovigilance 1998 May; 24: 8
3. 3. JS Wagener HA Wojtczak 1998 Inhaled steroids in children: risks versus rewards J Pediatr 132 381 3 9544884 10.1016/S0022-3476(98)70003-4 1:STN:280:DyaK1c3gsVCntw%3D%3D Wagener JS, Wojtczak HA. Inhaled steroids in children: risks versus rewards. J Pediatr 1998 Mar; 132: 381–3
4. 4. CGD Brook 1998 Short stature never killed anybody J Pediatr 133 591 2 9821412 10.1016/S0022-3476(98)70095-2 1:STN:280:DyaK1M%2FjvVymsQ%3D%3D Brook CGD. Short stature never killed anybody. J Pediatr 1998; 133: 591–2
5. 5. Drug Ther Perspect 1997 9 8 Apr 28 Prompt control of asthma essential: the emphasis from the new US and UK guidelines. Drug Ther Perspect 1997 Apr 28; 9(8): 6–8
6. 6. EF Juniper PA Kline MA Vanzieleghem 1990 Effect of long-term treatment with an inhaled corticosteroid (Budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics Am Rev Respir Dis 142 832 6 2221590 1:STN:280:DyaK3M%2FitlOhtQ%3D%3D Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with an inhaled corticosteroid (Budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142: 832–6
7. 7. A Ault 1998 Steroids need stricter paediatric growth warnings Lancet 352 461 10.1016/S0140-6736(05)79200-X Ault A. Steroids need stricter paediatric growth warnings. Lancet 1998 Aug 8; 352: 461
8. 8. FoodDrug Administration 1998 FDA requires new pediatric labeling for inhaled, intranasal corticosteroids Media release Nov 9 [2 pages] Food and Drug Administration. FDA requires new pediatric labeling for inhaled, intranasal corticosteroids. Media release 1998 Nov 9 [2 pages]
9. 9. IJM Doull MJ Campbell ST Holgate 1998 Duration of growth suppressive effects of regular inhaled corticosteroids Arch Dis Child 78 172 3 9579164 10.1136/adc.78.2.172 1:STN:280:DyaK1c3ktVehtQ%3D%3D Doull IJM, Campbell MJ, Holgate ST. Duration of growth suppressive effects of regular inhaled corticosteroids. Arch Dis Child 1998 Feb; 78: 172–3
10. 10. R Covar DYM Leung MTS Chan 1999 Risk factors associated with glucocorticoid (GC) side effects in adolescents with severe asthma — revisited J Allergy Clin Immunol 103 S61 [abstract] Covar R, Leung DYM, Chan MTS, et al. Risk factors associated with glucocorticoid (GC) side effects in adolescents with severe asthma — revisited [abstract]. J Allergy Clin Immunol 1999 Jan; 103 Pt 2: S61
11. 11. DP Skoner M Welch D Tinkleman 1999 Inhaled corticosteroid-induced growth retardation in asthmatic children in a ‘Real World’ setting J Allergy Clin Immunol 103 S61 [abstract] Skoner DP, Welch M, Tinkleman D, et al. Inhaled corticosteroid-induced growth retardation in asthmatic children in a ‘Real World’ setting [abstract]. J Allergy Clin Immunol 1999 Jan; 103 Pt 2: S61
12. 12. OM Chay A Goh WH Lim 1999 Effects of inhaled corticosteroid on bone turnover in children with bronchial asthma Respirology 4 63 7 10339732 10.1046/j.1440-1843.1999.00148.x 1:STN:280:DyaK1M3ntFSqsg%3D%3D Chay OM, Goh A, Lim WH. Effects of inhaled corticosteroid on bone turnover in children with bronchial asthma. Respirology 1999 Jan; 4: 63–7
13. 13. JM DeMasi 1999 Steroid use and bone metabolism in pediatric asthmatics J Allergy Clin Immunol 103 S132 [abstract] DeMasi JM. Steroid use and bone metabolism in pediatric asthmatics [abstract]. J Allergy Clin Immunol 1999 Jan; 103 Pt 2: S132
14. 14. OD Wolthers S Pedersen 1993 Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate Arch Dis Child 68 5 673 6 8323338 10.1136/adc.68.5.673 1:STN:280:DyaK3szht1SltQ%3D%3D May Wolthers OD, Pedersen S. Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. Arch Dis Child 1993 May; 68(5): 673–6
15. 15. C MacKenzie 1998 Effects of inhaled corticosteroids on growth J Allergy Clin Immunol 101 4 S451 5 9563371 10.1016/S0091-6749(98)70158-7 1:CAS:528:DyaK1cXivVSqur4%3D Apr MacKenzie C. Effects of inhaled corticosteroids on growth. J Allergy Clin Immunol 1998 Apr; 101 (4 Pt 2): S451–5
16. 16. AC Ferguson S Spier A Manjra 1999 Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide J Pediatr 422 7 Apr Ferguson AC, Spier S, Manjra A, et al. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide. J Pediatr 1999 Apr; 422–7
17. 17. JTC Li MF Goldstein GN Gross 1999 Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis J Allergy Clin Immunol 103 4 622 9 10200011 10.1016/S0091-6749(99)70234-4 1:CAS:528:DyaK1MXivVCmtb0%3D Apr Li JTC, Goldstein MF, Gross GN, et al. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol 1999 Apr; 103(4): 622–9
18. 18. J Baker J Yunginger K Walton-Bowen 1998 A safety and HPA-axis evaluation of four dose regimens of budesonide nebulizing suspension (BNS; pulmicort® respules™) compared with placebo (PBO) in infants and young children with persistent asthma Am J Respir Crit Care Med 157 A405 [abstract] Baker J, Yunginger J, Walton-Bowen K, et al. A safety and HPA-axis evaluation of four dose regimens of budesonide nebulizing suspension (BNS; pulmicort® respules™) compared with placebo (PBO) in infants and young children with persistent asthma [abstract]. Am J Respir Crit Care Med 1998; 157: A405
19. 19. AA Irani A Nayak M Cruz-Rivera 1999 HPA-axis function in infants and young children with persistent asthma treated for 52 weeks with budesonide inhalation suspension (BIS; pulmicort respules™) J Allergy Clin Immunol 103 S130 1 [abstract] Irani AA, Nayak A, Cruz-Rivera M, et al. HPA-axis function in infants and young children with persistent asthma treated for 52 weeks with budesonide inhalation suspension (BIS; pulmicort respules™) [abstract]. J Allergy Clin Immunol 1999 Jan; 103 Pt 2: S130–1